NuvemRx announced that it has acquired the 340B referral capture business formerly known as par8o from R1 RCM.
Founded in 2011, par8o is a healthcare technology company specializing in 340B referral capture with expansive integrations with major pharmacy partners. par8o advances access to care for safety-net healthcare organizations by turning eligible outpatient referrals into compliant 340B savings at scale. par8o was acquired by R1 RCM as part of the Cloudmed transaction announced in December 2021.
NuvemRx, backed by Parthenon Capital, helps community health providers deliver on their mission by simplifying the complexity of pharmacy operations. NuvemRx provides pharmacy–enablement and referral-management services for community health centers, supporting 340B contract-pharmacy administration, in-house pharmacy operations and specialty-care referral coordination.
The acquisition expands NuvemRx’s ability to help covered entities more effectively capture specialty referrals, retain patients within their networks, comply with ongoing rebate and reimbursement changes and grow eligible prescription savings. With par8o’s network added to its suite of services, NuvemRx will now support more than 800 covered entities nationwide. Financial terms of the deal were not disclosed.
According to data captured in the LevinPro HC database, this transaction represents the 38th eHealth transaction of the year, and the 11th in the medical practice management software (MPMS) specialty. There were 53 MPMS transactions announced in 2025, and 59 announced in 2024.
